TrialSignal
Clinical trial intelligence report
An In-home Study of Brain Computer Interfaces
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT01123200-Jul 28, 2026
NCT ID
NCT01123200
Status
COMPLETED
Phase
Completed
Sponsor
University of Michigan
Executive brief
Investment-Ready Snapshot
The University of Michigan's study on brain-computer interfaces (BCIs) aims to enhance the independence of individuals with severe paralysis, particularly those with Amyotrophic Lateral Sclerosis (ALS). The market for assistive technologies is growing, driven by an increasing aging population and rising prevalence of neurological disorders. The unique nature of this BCI technology, which allows users to control wheelchairs and communicate, positions it competitively against existing assistive devices. However, the limited enrollment (only one participant) raises concerns regarding scalability and market viability. Further exploration of user experience and technology refinement will be critical for commercial success.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01123200
Indication
Amyotrophic Lateral Sclerosis
Modality
medical device
Target
Brain-computer interface (BCI) technology for assistive communication and control of electronic devices.
Intervention
Brain Computer Interface for Wheelchair Tilt Control
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.